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Abstract
Background: Thymic lymphoid hyperplasia is often present with myasthenia gravis as well as other autoimmune
diseases such as systemic lupus erythematosus and rheumatoid arthritis. Of the 4 cases of thymic lymphoid
hyperplasia associated with Sjögren syndrome that have been reported, no case with a thymic lesion diagnosis that
led to the diagnosis of Sjögren syndrome has been reported. We herein report a case of thymic lymphoid
hyperplasia with multilocular thymic cysts, diagnosed before Sjögren syndrome.
Case presentation: A 37-year-old Japanese woman had an approximate 5-cm anterior mediastinal mass detected
by chest imaging. The resected lesion revealed multilocular thymic cysts that were filled with colloid-like material.
Histology showed lymph follicular hyperplasia with many epithelial cysts. The epithelium consisted of thymic
medullary epithelium, and no epithelial proliferation was seen in the lymphoid tissue. Lymphocytes were composed
of an organized mixed population of mature T and B cells without significant atypia. The infiltrated B cells did not
reveal light chain restriction or immunoglobulin heavy chain gene rearrangement. After the pathological diagnosis
of thymic lesion, tests for the presence of autoantibodies were positive for antinuclear antibodies, rheumatic factor,
and anti-SSA/Ro antibodies. The Schirmer’s, chewing gum, and Saxon tests showed decreased salivary and lacrimal
secretion. Lip biopsy showed focal lymphocytic sialadenitis. The signs and symptoms of Sjögren syndrome had not
resolved, without aggravation, 1 year after the thymectomy.
Conclusion: When a case with thymic lymphoid hyperplasia without myasthenia gravis is encountered, it is
essential to consider the presence of another autoimmune disease including Sjögren syndrome.
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Background
Thymic lesions in Sjögren syndrome primarily
consist of extranodal marginal zone B-cell (MALT)
lymphoma and rarely consist of thymoma, thymic
carcinoma, or lymphoid hyperplasia [1]. Of the 4
cases with thymic lymphoid hyperplasia associated
with Sjögren syndrome that have been reported [1–3],
3 cases were accompanied by multilocular thymic cysts.
We herein report a case of thymic lymphoid hyperplasia
with multilocular thymic cysts that led to the diagnosis
of preclinical Sjögren syndrome. To the best of our know-
ledge, a diagnosis of thymic lymphoid hyperplasia before
the diagnosis of Sjögren syndrome has not previously
been reported.
Case presentation
A 37-year-old Japanese woman was referred to our hos-
pital for general malaise. Chest radiography, computed
tomography (CT), and magnetic resonance imaging re-
vealed a superior anterior mediastinal tumor that was
4.7 × 3.8 × 2.8 cm in size, with multilocular cysts. CT with
contrast enhancement showed mild enhancement of the
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septum of the lesion (Fig. 1a-c). T1-weighted and
T2-weighted images revealed isointensity and high
intensity, respectively, of the lesion (Fig. 1d). Calcification
or fatty components were not seen. The positron emission
tomography standardized uptake value (PET SUVmax)
was 4.25, which was relatively low (Fig. 1e). The following
tumor markers were all within normal range:
carcinoembryonic antigen, alpha-fetoprotein, squamous
cell carcinoma antigen, CYFRA 21–1, sialyl Lewis X, and
progastrin-releasing peptide. Anti-acetylcholine receptor
antibodies were not detected. Thymoma, thymic cyst, or
teratoma was suspected, and a thymectomy was performed.
After the pathological diagnosis, on suspicion of an
associated autoimmune disease, autoantibodies were
examined and were positive for antinuclear antibodies
(speckled type, ×640), rheumatic factor (114; normal range
<15 IU/mL), and anti-SSA/Ro antibodies (>240; normal
<10 U/mL) and negative for anti-SS-B/La, anti-DNA, anti-
RNP, anti-Sm, anti-cyclic citrullinated peptide, Jo-1, Scl-70,
and anti-neutrophil cytoplasmic antibodies (MPO-ANCA
and PR3-ANCA). She also had a mildly dry mouth and dry
eyes. The Schirmer’s (right 2 mm/left 2 mm), chewing gum
(2.9 mL/10 min), and Saxon (0.62 g/2 min) tests all showed
decreased secretion of the lacrimal and salivary glands. A
lip biopsy specimen revealed focal lymphocytic sialadenitis.
Based on these findings, Sjögren syndrome was diagnosed.
The signs and symptoms of Sjögren syndrome, without
aggravation, were not resolved 1 year after the thymectomy,
and autoantibody titers did not show remarkable changes.
Pathological findings
The resected thymectomy specimen was 9.5 × 5.5 ×
2.5 cm in size and weighed 61 g. An ill-defined elastic
firm mass, 5 × 3.5 × 2.5 cm in size, was found in the
thymus with multilocular cysts, many of which were
filled with yellowish-green colloid-like material (Fig. 2).
Histology of the tumor revealed lymphoid tissue with
hyperplastic germinal centers and occasional Hassall
corpuscles (Fig. 3). The cysts were lined by thin layers of
thymic epithelium (Fig. 4). Outside the tumor in the
thymus, there were many small nodules of lymphoid tissue
showing similar morphology as the main tumorous lesion.
In the small nodules of lymphoid tissue, microscopic cysts
lined by thymic epithelium were occasionally found (Fig. 5).
The lymphocytes were small and mature except for cells in
germinal centers. No significant atypia was seen in the
Fig. 1 Radiological imaging of the lesion. Contrast-enhancement computed tomography (CT) shows a tumor in the superior anterior mediastinum
with slightly enhanced multiple septa (a-c). Magnetic resonance imaging (MRI) with fat suppression reveals the tumor with high-intensity (d). The
standardized uptake value (SUVmax) of positron emission tomography (PET)-CT was 4.25, which was relatively low (e)
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lymphoid and epithelial cells. Immunohistochemically,
cytokeratin AE1/AE3 highlighted the epithelium of the
cysts and Hassall corpuscles (Fig. 6). There was no epithe-
lial proliferation in the nodular lymphoid tissue; the find-
ings eliminated the possibility of thymoma. Lymphoid
markers revealed organized mixed distribution of CD3+,
CD5+, CD20+, and CD79+ cells and did not show mono-
clonal proliferation of B cells or T cells (Fig. 7a,b). Immu-
nostaining of light chains showed that the approximate
ratio of kappa to lambda was 3:1, and no significant
light chain restriction was seen (Fig. 7c,d). Staining of im-
munoglobulin (Ig)G, IgA, and IgM heavy chains did not
reveal monoclonal proliferation. Both CD20 + B cells and
CD3 +T cells infiltrated the epithelium. No aberrant
expression of CD5 and CD43 B cells was observed. Bcl-2
was negative in the germinal center of lymphoid follicles.
Polymerase chain reaction and gene analysis from
the formalin-fixed paraffin embedded tissue of the lesion
did not show rearrangement of the immunoglobulin
heavy chain (IgH) gene. Thymic lymphoid hyperplasia
with multilocular thymic cysts was the pathological
diagnosis.
The lip biopsy specimen revealed mild atrophy of the
minor salivary glands with mild fibrosis and focal lymphoid
aggregation (Fig. 8). A lymphoepithelial lesion was not seen.
The focus score [4] was 1.25 and was graded [5] as 4.
Fig. 2 Macroscopic findings of the thymic tumor. An ill-defined tumor (5 × 3.5 × 2.5 cm) is seen in the upper part of the resected thymus (arrow)
(a). The cut surface shows a multicystic tumor filled with yellowish-green colloid-like material (b)
Fig. 3 Histological findings of the thymic tumor. Lower power view
shows the cystic walls are composed mostly of lymphoid tissue with
epithelial linings. Cysts are filled with eosinophilic proteinous secretion
containing cholesterol clefts
Fig. 4 Histologic findings of the cyst wall. Higher power view
reveals that the cyst wall consists of mature small lymphocytes with
a germinal center (right lower) and thymic medullary epithelium
with Hassall corpuscles
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Discussion
To the best of our knowledge, this is the first report of
thymic lymphoid hyperplasia that led to the diagnosis of
preclinical Sjögren syndrome. The lesion was accompan-
ied by multilocular thymic cysts.
Thymic cysts are categorized as either congenital and
acquired; the former is usually unicystic and non-
inflammatory, and the latter is generally multicystic and
associated with other diseases such as thymoma, thymic
carcinoma, malignant lymphoma including MALT
lymphoma, Hodgkin lymphoma, germ cell tumor, HIV
infection, or lymphoid hyperplasia [1, 6]. Both unicystic
and multicystic lesions are lined with flattened, cuboidal,
ciliated columnar or stratified squamous epithelium, but
multilocular thymic cysts are most likely the result of
cystic transformation of medullary epithelium induced by
an acquired inflammatory process [6]. The microscopic
cysts found in the non-tumorous area of the present case
suggest the beginning of such an acquired process.
Although the occurrence of thymic lymphoid hyperplasia
is relatively rare, it is most commonly associated with myas-
thenia gravis (MG). Aside from MG, thymic lymphoid
hyperplasia is most often accompanied with other auto-
immune diseases such as systemic lupus erythematosus,
rheumatoid arthritis, scleroderma, Sjögren syndrome, aller-
gic vasculitis, and Hashimoto thyroiditis [1, 7]. In contrast
to true thymic hyperplasia, thymic lymphoid hyperplasia
usually does not show thymic enlargement but an increased
number of lymphoid follicles [7]. Numerous hyperplastic
germinal centers with tingible body macrophages and cen-
troblastic and centrocytic cells are usually present [8]. The
mantle zone is well defined, while the marginal zone is not
developed. A normal thymic cortex is observed around the
areas of lymphoid hyperplasia, and effacement of the
thymic architecture with cortical atrophy is not seen. Dif-
ferentiation from MALT lymphoma, Castleman disease,
and lymphocyte predominant thymoma (type B1) is
important.
In MALT lymphoma, interfollicular expansion of
centrocyte-like cells, monocytoid B-cells, or plasmacy-
toid cells fill the medullary spaces and partially infiltrate
reactive follicles (follicular colonization) with atrophic
mantle zones. Nuclei of infiltrating lymphocytes are
irregular with dense chromatin and occasional blastoid
larger cells. These findings were not observed in the
present case. Furthermore, each follicle is not surrounded
by an epithelial network, as observed in the present case,
and invasion of monocytoid B-cells or centrocyte-like
lymphocytes with irregular nuclei are observed in MALT
lymphoma. The present case did not have monoclonal
proliferation of lymphocytes and plasma cells, and the
genetic analysis from the formalin-fixed paraffin embed-
ded tissue of the lesion did not show rearrangement of the
IgH gene.
A hyaline vascular type of Castleman disease typically
shows germinal centers containing a few small vessels
bridging through to perifollicular tissue and is surrounded
by concentrically arranged small lymphoid cells, whereas a
plasma cell type shows diffuse sheet-like infiltration of
plasma cells in the interfollicular zone. The present case
did not show the typical histopathological changes of ei-
ther type of Castleman disease.
A literature search in the PubMed database resulted in
22 cases of MALT lymphoma, 6 cases of thymoma,
4 cases of lymphoid hyperplasia, and 1 case of thymic
carcinoma associated with Sjögren syndrome. Of the
4 cases of thymic lymphoid hyperplasia associated with
Fig. 5 Histological findings of the thymus. Non-tumorous thymic
tissue also shows hyperplastic lymphoid tissue with many germinal
centers. Occasionally, microscopic cystic lesions (right upper) similar
to the tumorous lesion are seen in the thymus
Fig. 6 Immunohistochemical findings of the epithelial marker.
Immunohistochemistry of cytokeratin AE1/AE3 highlights the
organized network of the thymic medullary epithelium surrounding
hyperplastic lymphoid tissue. No epithelial proliferation is seen in the
nodular lymphoid tissue
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Sjögren syndrome [1–3], 3 cases were accompanied by
multilocular thymic cysts [1, 3]. To the best of our know-
ledge, a diagnosis of thymic lymphoid hyperplasia before
the Sjögren syndrome diagnosis has not been reported
previously. Although the preoperative signs and symptoms
were mild, the patient fulfilled the criteria of primary
Sjögren syndrome [9], including decreased secretion of the
lacrimal and salivary glands, presence of autoantibodies to
SSA/Ro, and a focus score >1 for the lip biopsy [10]. The
patient had no history of other collagen vascular diseases,
radiation therapy, hepatitis C infection, acquired immuno-
deficiency disease, malignant lymphoma, sarcoidosis,
graft-versus-host disease, or use of anticholinergic drugs.
Although thymectomy leads to remission in a significant
number of MG patients with thymic lymphoid hyperplasia
[11–13], the disease outcome differs [11–13], especially in
those with different types of autoantibodies [11]. Thymec-
tomy did not appear to improve the sicca symptoms or to
decrease the serum level of anti-SSA/Ro antigens in the
present patient. Izumi, et al. [1] reported that the serum
ANA levels remained high after thymectomy in two
patients with Sjögren syndrome and thymic follicular
hyperplasia, although without aggravation of their condi-
tion. We do not know which came first, the thymic lesion
or Sjögren syndrome. Based on the experience of these few
cases, Sjögren syndrome might develop first. However, even
if the thymic lesion develops first, resection of thymic
lesions might not improve, or only gradually improve, the
autoimmune diseases that show poor response to cortico-
steroids, when compared with MG [14].
Conclusions
We report a case of thymic lymphoid hyperplasia with
multilocular thymic cysts, which led to the diagnosis of
Fig. 8 Histological findings of the minor salivary gland. Histology of
the labial minor salivary gland shows focal lymphocytic aggregation
in the gland with mild glandular atrophy. A lymphoepithelial lesion
is not seen. The focus score was 1.25 and was graded as 4
Fig. 7 Immunohistochemical findings of the lymphoid markers. Immunohistochemistry of CD3 (a) and CD20 (b) shows mixed distribution of T
and B cells and does not show any monoclonal proliferation. Both CD20 + B cells and CD3+ T cells infiltrate the lining epithelium of the cyst.
Immunostaining of light chains (c, d) does not show restriction of kappa (c) or lambda (d) chains
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preclinical Sjögren syndrome. When we encounter a
case with thymic lymphoid hyperplasia, we should con-
sider the presence of autoimmune diseases. The precise
mechanism underlying the association between Sjögren
syndrome and thymic lesions is yet to be determined.
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